ABBOTT LABORATORIES — Director's Dealing 2015

Jun 3, 2015

SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person YOOR BRIAN B (Last) (First) (Middle) 100 ABBOTT PARK ROAD (Street) ABBOTT PARK IL 60064 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 06/01/2015	3. Issuer Name and Ticker or Trading Symbol ABBOTT LABORATORIES [ ABT ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Senior Vice President and CFO			5. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)			2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common shares without par value			18,146	D
Common shares without par value			2,043 (1)	I	Profit Sharing Trust
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy) (2)	02/15/2016	02/14/2023	Common shares	11,400	34.94	D
Option (right to buy) (2)	02/21/2015	02/20/2024	Common shares	10,788	39.12	D
Option (right to buy) (2)	02/21/2016	02/20/2024	Common shares	10,787	39.12	D
Option (right to buy) (2)	02/21/2017	02/20/2024	Common shares	10,788	39.12	D
Option (right to buy) (2)	02/20/2016	02/19/2025	Common shares	13,743	47	D
Option (right to buy) (2)	02/20/2017	02/19/2025	Common shares	13,743	47	D
Option (right to buy) (2)	02/20/2018	02/19/2025	Common shares	13,743	47	D

Explanation of Responses:

1. Balance in the Abbott Laboratories Stock Retirement Trust as of June 1, 2015.
2. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

John A. Berry, by power of attorney for Brian B. Yoor 06/03/2015

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 5 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

http://www.sec.gov/Archives/edgar/data/1800/000117911015009073/xslF345X02/edgar.xml

6/3/2015